Abstract
Introduction: Despite all progress in vaccine research against toxoplasmosis, subunit vaccines still deal with poor immunogenicity, which could be overcome by using efficient delivery vehicles like PLGA. The proteinaceous nature of antigens makes the loading of protein more challenging than chemical medicines. Here, we prepared rSAG1-PLGA by adsorption and encapsulation methods and compared their characterizations. Methods and Results: Blank PLGA and rSAG1-encapsulated PLGA nanospheres were prepared using double emulsion solvent evaporation technique at room temperature. rSAG1-adsorbed PLGA nanospheres were prepared by incubating a suspension of freeze-dried blank PLGA with rSAG1 in PBS (pH 7.4) and it was mixed at 4°C overnight. Size, PDI, zeta potential, preparation yield, and adsorption/encapsulation efficiency of all prepared PLGA nanospheres were characterized and summarized in table below: Formulation Size (nm) PDI* Zeta potential (mV) A/E efficiency (%) Yield (%) Blank PLGA 438 ± 11 0.12 ± 0.01 -5.56 ± 0.68 - 86.8 ± 3.56 rSAG1-adsorbed PLGA 486 ± 9.9 0.14 ± 0.02 -1.00 ± 0.33 69.73 ± 3.05 87.4 ± 2.7 rSAG1-encapsulated PLGA 471 ± 8.5 0.20 ± 0.04 -4.66 ± 0.6 46.93 ± 2.51 86.8 ± 2.86 *Poly Dispersity Index, A; adsorption, E; encapsulation Moreover, in vitro release profile of both PLGA nanospheres during 4 weeks demonstrated more or less similar release pattern (zero-order release patterns). However, rSAG1 release in rSAG1-encapsulated PLGA happened slower than release in rSAG1-adsorbed one. Conclusions: Based on obtained size, both rSAG1-adsorbed and rSAG1-encapsulated particles could be efficiently taken up by presenting cells. Higher efficiency of adsorption than encapsulation makes adsorption method more economic in large scale. Protein during encapsulation process faces some stability problems due to exposure to harsh mechanical thermal and chemical stresses affecting protein integrity and immunogenicity. Therefore, protein adsorption would be applied as a suitable method for protein loading. We are going to evaluate the efficiency of both particles in eliciting immune responses in BALB/c. Keywords: adsorption, encapsulation, PLGA, rSAG1, Toxoplasma gondii Grants: Iran National Science Foundation (INSF), Project No. 90005424.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.